Tiziana Life Sciences (TLSA) Other Non-Current Liabilities (2019 - 2025)

Tiziana Life Sciences has reported Other Non-Current Liabilities for 7 years, with the latest figure at -$3000.0 in Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities fell 125.0% year-over-year to -$3000.0 in Q4 2025; TTM through Dec 2025 was -$3000.0, a 125.0% decrease from a year earlier, with the FY2025 full-year figure at -$3000.0, down 125.0% from the prior year.
• Other Non-Current Liabilities was -$3000.0 for Q4 2025 at Tiziana Life Sciences, down from $9000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $83000.0 in Q2 2021, with the low at -$3000.0 in Q4 2025.
• Average Other Non-Current Liabilities over 5 years is $15600.0, with a median of $9000.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities soared 55.56% in 2023, then sank 125.0% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $10000.0 in 2021, then retreated by 10.0% to $9000.0 in 2022, then jumped by 55.56% to $14000.0 in 2023, then dropped by 14.29% to $12000.0 in 2024, then tumbled by 125.0% to -$3000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at -$3000.0 (Q4 2025), $9000.0 (Q2 2025), and $12000.0 (Q4 2024), per Business Quant data.